Overview

Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa

Status:
Terminated

Trial end date:
2013-11-01

Target enrollment:

Participant gender:

Summary

The primary objective is to establish superiority of AZCQ over SP in protective efficacy for IPTp as measured by the proportion of subjects with sub-optimal pregnancy outcome.

Phase:

Phase 3

Details

Lead Sponsor:

Pfizer

Collaborators:

London School of Hygiene and Tropical Medicine
Medicines for Malaria Venture

Treatments:

Azithromycin
Chloroquine
Chloroquine diphosphate
Fanasil, pyrimethamine drug combination
Pyrimethamine
Sulfadoxine